ࡱ> =?<y bjbj 4 {{  82 >,7 fjjjjjEEE$!O$EEEEEjjUUUELjjx>UEUUL|j`ą^d 07 %%$%xEEUEEEEEUEEE7 EEEE%EEEEEEEEE : ENGLISH SUMMARY OF PRODUCT CHARACTERISTICS 6.4 Special precautions for storage <30(C>> or <30(C>> * ** > >**** **** **** ***** > A. LABELLING 9. SPECIAL STORAGE CONDITIONS <30(C>> or <30(C>> * ** > >**** **** **** > B. PACKAGE LEAFLET 5. STORING X <30(C>> or <30(C>> * ** > >**** **** **** ***** > * The stability data generated at 25(C/60%RH (acc) should be taken into account when deciding whether or not transport under refrigeration is necessary. The statement should only be used in exceptional cases. ** The statement should be used only when critical. *** The actual name of the container should be used (e.g. bottle, blister, etc.) **** It should be specified if the product is sensitive to light and/or moisture. ***** Depending on the pharmaceutical form and the properties of the product, there may be a risk of deterioration due to physical changes if subjected to low temperatures. Low temperatures may also have an effect on the packaging in certain cases. An additional statement may be necessary to take account of this possibility.      Qjkqr   ) * 0 1   2 3 8 9 JS -.hh'jh'UhumH sH h1MhumHsHhu5mHsH jhu hu5huJ  -.RSy G l : 7^7` & F]3$)$d%d&d'd-DM NOPQ])a$  5 O s z\kd$$Ifl 0 4 la }7$If^7`$ (5a$ &d P   Q R  > g D & F] & F7]^7`$a$ &d P  7(5D ab $a$ &d P  & F]      & F] 2 00&P . A!S"S#n$n% m$$If!vh#v :V l0 5 4^ 666666666vvvvvvvvv666666>6666666666666666666666666666666666666666666666666hH6666666666666666666666666666666666666666666666666666666666666666662 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~_HmH nH sH tH <`< NormalCJ_HmH sH tH J@J  Heading 1$$@&a$5B*CJ ph@@@  Heading 2$$@&a$5\DA D Default Paragraph FontVi@V 0 Table Normal :V 44 la (k ( 0No List L @LFooter  r CJOJQJmHnHu@@@ Header  9r  CJOJQJ\O\ MemoHeaderStyle$dx^a$5:OJQJHC@"H Body Text Indent 7^76TO2T EMEA En Body Text$xxa$mH sH bO12b EMEA En Heading 1$$ $7h^7`5;DOD subhead  7n@@5;OJQJPORP main head 7n@@5;CJOJQJ@Q@r@  Body Text 3$a$mH sH <+@<  Endnote Text  7@@@  Comment Text CJmH sH ZOZ Uberschrift 2$ 7x5KHOJQJ8O8 EMEA Body TextXOX EMEA Heading 1$$7@&^7`5;H@H kU Balloon TextCJOJQJ^JaJPK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭V$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3N)cbJ uV4(Tn 7_?m-ٛ{UBwznʜ"Z xJZp; {/<P;,)''KQk5qpN8KGbe Sd̛\17 pa>SR! 3K4'+rzQ TTIIvt]Kc⫲K#v5+|D~O@%\w_nN[L9KqgVhn R!y+Un;*&/HrT >>\ t=.Tġ S; Z~!P9giCڧ!# B,;X=ۻ,I2UWV9$lk=Aj;{AP79|s*Y;̠[MCۿhf]o{oY=1kyVV5E8Vk+֜\80X4D)!!?*|fv u"xA@T_q64)kڬuV7 t '%;i9s9x,ڎ-45xd8?ǘd/Y|t &LILJ`& -Gt/PK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!0C)theme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK]      D  8@0(  B S  ?          :LP?CJS`  "Y?$   UX $9\L-m elxje! h8^h` Figure: . @77^7`.@hh^h`.RR^R`.RR^R`..RR^R`...RR^R`....^`()pp^p`()  ^ `.@ @ ^@ `.  ^ `.::^:`o(.h^h`."Ye U$9\$ -m e'+)1M~N8U\_Nbd[f@9iq}quHn!=<(IQ,kU[  RegisteredVersion-10@ @UnknownG*Ax Times New Roman5Symbol3. *Cx Arial71 Courier5. .[`)TahomaA$BCambria Math"hUBgUBg2v}}!24 #9JQHP  $P1M2!xx HappendixIIIenGeneral-EMEA/288374/2007European Medicines AgencySYSTEM$      Oh+'0 ( 8D d p | HappendixIIIenGeneral-EMEA/288374/2007European Medicines AgencyNormalSYSTEM2Microsoft Office Word@@M,@ ^@ ^}՜.+,D՜.+,P  px  EMEA  HappendixIIIen Title+`6>JVbnz     *>Nbnz !"">#R$f%~&'()*) DM_Status DM_Authors DM_Keywords DM_Title DM_Language DM_Owner DM_emea_cc DM_emea_message_subject DM_emea_doc_number DM_emea_received_date DM_emea_resp_body DM_emea_revision_label DM_emea_to DM_emea_bccDM_emea_doc_category DM_emea_fromDM_emea_internal_labelDM_emea_legal_date DM_emea_yearDM_emea_sent_dateDM_emea_doc_langDM_emea_meeting_statusDM_emea_meeting_actionDM_emea_meeting_hyperlinkDM_emea_meeting_titleDM_emea_meeting_refDM_emea_meeting_flags DM_Subject DM_VersionDM_Name DM_Creation_Date!DM_Modify_Date"DM_Creator_Name#DM_Modifier_Name$DM_Type% DM_DocRefId& DM_Category'DM_Path(DM_emea_doc_ref_id)DM_Modifer_Name*DM_Modified_DatePrizzi Monica288374 nulldateGeneralEMEA nulldate2007 nulldateGeneral-EMEA/288374/2007 CURRENT,2.0HappendixIIIen02/02/2016 15:02:0203/02/2016 13:20:17 Akhtar Tia Akhtar Tiaemea_documentEMA/76700/2016General/02b. Administration of Scientific Meeting/WPs SAGs DGs and other WGs/CxMP - QRD/3. Other activities/02. Procedures/02. Annexes and appendices/02. Appendices/App III Storage/Human/Revision 02-2016 for publicationEMA/76700/2016 Akhtar Tia03/02/2016 13:20:17  !"#$%&'()*+-./012356789:;>Root Entry F`ą^@Data 1Table'%WordDocument4 SummaryInformation(,DocumentSummaryInformation84CompObjr  F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q